A phage-encoded RNA-binding protein inhibits the antiviral activity of a toxin–antitoxin system
Nucleic Acids Research · 09.02.2024 · 52 (3) · 1298-1312
DOI: 10.1093/nar/gkad1207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 20.12.2023. Verfasst von Chantal K Guegler und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: Bacteriophages, Toxin-Antitoxin Systems. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Howard Hughes Medical Institute, NSF.
Abstract (Originalsprache)
Bacteria harbor diverse mechanisms to defend themselves against their viral predators, bacteriophages. In response, phages can evolve counter-defense systems, most of which are poorly understood. In T4-like phages, the gene tifA prevents bacterial defense by the type III toxin–antitoxin (TA) system toxIN, but the mechanism by which TifA inhibits ToxIN remains unclear. Here, we show that TifA directly binds both the endoribonuclease ToxN and RNA, leading to the formation of a high molecular weight ribonucleoprotein complex in which ToxN is inhibited. The RNA binding activity of TifA is necessary for its interaction with and inhibition of ToxN. Thus, we propose that TifA inhibits ToxN during phage infection by trapping ToxN on cellular RNA, particularly the abundant 16S rRNA, thereby preventing cleavage of phage transcripts. Taken together, our results reveal a novel mechanism underlying inhibition of a phage-defensive RNase toxin by a small, phage-encoded protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
- Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
ORCID-Profile: Michael T Laub
Förderung
- NIGMS NIH HHS
- Howard Hughes Medical Institute
- NSF
- Howard Hughes Medical Institute Gilliam Fellowship
- Merck Fellow of the Jane Coffin Childs Fund for Medical Research
- Life Sciences Research Foundation
Zitieren
APA
Guegler, C. K., Teodoro, G. I. C., Srikant, S., Chetlapalli, K., Doering, C. R., Ghose, D. A., & Laub, M. T. (2024). A phage-encoded RNA-binding protein inhibits the antiviral activity of a toxin–antitoxin system. Nucleic Acids Research, 52(3), 1298-1312. https://doi.org/10.1093/nar/gkad1207
Vancouver
Guegler CK, Teodoro GIC, Srikant S, Chetlapalli K, Doering CR, Ghose DA, et al. A phage-encoded RNA-binding protein inhibits the antiviral activity of a toxin–antitoxin system. Nucleic Acids Research. 2024;52(3):1298-1312. doi:10.1093/nar/gkad1207
BibTeX
@article{Guegler2024,
author = {Guegler, Chantal K and Teodoro, Gabriella I C and Srikant, Sriram and Chetlapalli, Keerthana and Doering, Christopher R and Ghose, Dia A and Laub, Michael T},
title = {A phage-encoded RNA-binding protein inhibits the antiviral activity of a toxin–antitoxin system},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {3},
pages = {1298--1312},
doi = {10.1093/nar/gkad1207}
}
EUVIMED